Wednesday, 1 August 2012

Cancer Initiative Aims To Share Good Practice Across The NHS

This press release from QiC Oncology shows the success of the inaugural year of awards for excellence in oncology, with over 100 entries in 12 catagories.

Have been glad to be involved in this, putting forward the patients perspective.


Cancer initiative aims to share good practice across the NHS
QiC Excellence in Oncology awards ceremony will take place in November, 2012

Winners of the first Quality in Care (QiC) Excellence in Oncology programme will be announced on November 6 at The Hilton, Liverpool, during the National Cancer Research Institute (NCRI) annual conference ahead of plans to share the ideas behind this good care to an audience throughout the UK.

Supported by Cancer 52, Beating Bowel Cancer, the National Cancer Action Team, and industry partners such as Pfizer, BMS and Novartis to name but a few, the programme evolves from Pfizer’s successful Excellence in Oncology Awards and aims to recognise individuals or teams involved in the support, care and treatment of cancer patients in the UK across the NHS, voluntary and commercial sectors, with joint working and collaboration key to the QiC Programmes.

In its inaugural year, the programme has received more than 100 entries across 12 categories, which include Cancer Professional of the Year and Cancer Charity Initiative of the Year, as well as awards in line with the NHS Outcomes Framework, such as Patient Experience and Patient Safety.

There is also a Lifetime Achievement Award, given to an individual who has made an outstanding contribution to the field of cancer throughout their lifetime.

Regarding the number and quality of entries, Rob Day, UK Oncology Business Unit Head, Pfizer, said: “This is an excellent achievement and really demonstrates the importance of and interest in the awards.”

Following the awards, winning work will be showcased at events across the country, and will feature in QiC Connect – an online knowledge hub for healthcare practice in the UK accessible at

Stephen Parsons, Director, National Cancer Action Team said: "The National Cancer Action Team believes that QiC Excellence in Oncology provides an effective means of both celebrating and learning from new ways of working which will help to drive up the quality of care."

Jenny Ritchie-Campbell, Director, Cancer Services Innovation, Macmillan Cancer Support said: "Macmillan Cancer Support aims to support people with cancer every step of the way and push for better cancer care. We are delighted to support the Quality in Care Oncology programme which will identify and share good practice and help to spread the expertise and knowledge of successful innovations."

Pat Haye, Director, Thames Valley Cancer Network said: "Cancer Networks are a vehicle to drive quality improvements, which is achieved by working in collaboration with many clinical teams and partners. The TVCN sees these awards as a way of recognising the invaluable work and contribution of these teams that continuously deliver innovative, effective cancer care.”

Visit for further details on QiC Excellence in Oncology, including the full list of categories and supporters. Finalists will be announced on the QiC website in the middle of September.

For details on how to book a ticket for the awards ceremony in November, contact Louise Bellamy at

Further information about QiC Excellence in Oncology:

Quality in Care is a series of programmes aimed at recognising quality and productivity in line with the Department of Health agenda around QIPP. The ultimate aim of the programme is to identify, showcase and share initiatives which have been created in the NHS and are already helping to improve the quality and productivity of diabetes care. Other current QiC programmes include QiC Diabetes, while future programmes will cover rheumatology and respiratory disorders.
Website: http://
Twitter: @qicprogramme

PMGroup is a leading international multi channel media group, dedicated to the pharmaceutical sector, extending beyond the UK into Europe and the US. PMGroup core brands include: Pharmaceutical Market Europe; The Directory; Communiqué;; Communiqué Awards and the Pharmaceutical Market Excellence Awards (PMEA).

No comments:

Post a Comment